发明名称 A neuropilin and vascular endothelial growth factor (VEGF) complex and uses thereof in hibitng bioactiviy of growth factors in tumor cells
摘要 An isolated ligand-receptor complex is described wherein the ligand comprises a polypeptide that binds to NP-1 receptor and has at least 95% sequence identity with the amino acid sequence encoded by exon 6B of VEGF-B167 and the receptor comprises a polypeptide that has at least 95% sequence identity with the extracellular domain of NP-1 and binds to VEGF-B167 or VEGF-C or wherein the ligand is selected from VEGF-B167, processed VEGF-B167, VEGF-C and VEGF-D, and the receptor comprises a polypeptide that binds to VEGF-B167, processed VEGF-B167 or VEGF-C and has at least 95% sequence identity to the extracellular domain of NP-1. Polypeptides comprising the amino acid sequence encoded by exon 6B of VEGF-B167 can be used in the manufacture of a medicament for inhibiting bioactivity of a growth factor selected from to VEGF-B167, processed VEGF-B167, VEGF-C and VEGF-D. Uses and methods for modulating the responsiveness of cells to collapsing/semaphoring glycoproteins and for inhibitng growth or proliferation of tumor cells, and antibodies and vectors are also described.
申请公布号 NZ511115(A) 申请公布日期 2005.01.28
申请号 NZ19990511115 申请日期 1999.10.19
申请人 LUDWIG INSTITUTE FOR CANCER RESEARCH;LICENTIA LTD 发明人 ALITALO, KARI;ERIKSSON, ULF;OLOFSSON, BRIGITTA;MAKINEN, TAIJA
分类号 C12N15/09;A61K38/22;A61K47/48;A61P9/00;A61P17/06;A61P27/02;A61P35/00;A61P43/00;C07K14/475;C07K14/52;C07K14/71;C07K14/715;C07K16/28;C07K19/00;C12N5/06;C12P21/08;C12Q1/02;(IPC1-7):A61K38/18;C07K16/22;C07K14/485 主分类号 C12N15/09
代理机构 代理人
主权项
地址